321 related articles for article (PubMed ID: 15891124)
1. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.
Villahermosa LG; Fajardo TT; Abalos RM; Balagon MV; Tan EV; Cellona RV; Palmer JP; Wittes J; Thomas SD; Kook KA; Walsh GP; Walsh DS
Am J Trop Med Hyg; 2005 May; 72(5):518-26. PubMed ID: 15891124
[TBL] [Abstract][Full Text] [Related]
2. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
[TBL] [Abstract][Full Text] [Related]
4. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study.
Kaur I; Dogra S; Narang T; De D
Australas J Dermatol; 2009 Aug; 50(3):181-5. PubMed ID: 19659979
[TBL] [Abstract][Full Text] [Related]
6. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
Rattan R; Shanker V; Tegta GR; Verma GK
Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
[TBL] [Abstract][Full Text] [Related]
7. The role of thalidomide in the management of erythema nodosum leprosum.
Walker SL; Waters MF; Lockwood DN
Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
[TBL] [Abstract][Full Text] [Related]
8. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
Verma KK; Srivastava P; Minz A; Verma K
Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
[TBL] [Abstract][Full Text] [Related]
9. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide levels in patients with erythema nodosum leprosum.
Vieira JL; Valente Mdo S
Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
[TBL] [Abstract][Full Text] [Related]
11. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].
Ishii N; Ishida Y; Okano Y; Ozaki M; Gidoh M; Kumano K; Goto M; Nogami R; Hatano K; Yamada A; Yotsu RR
Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):275-85. PubMed ID: 21941834
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of erythema nodosum leprosum using thalidomide].
Sheskin J
Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
[No Abstract] [Full Text] [Related]
14. Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual?
Mahajan VK; Chauhan PS; Sharma NL; Sharma AL; Mehta KS
Braz J Infect Dis; 2011; 15(1):90-1. PubMed ID: 21412598
[No Abstract] [Full Text] [Related]
15. Canadian case report of erythema nodosum leprosum successfully treated with prednisone and thalidomide.
Saber M; Bourassa-Fulop C; Bouffard D; Provost N
J Cutan Med Surg; 2010; 14(2):95-9. PubMed ID: 20338126
[TBL] [Abstract][Full Text] [Related]
16. Elevated platelet counts and thrombocytosis in erythema nodosum leprosum.
Rea TH
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):167-73. PubMed ID: 12483964
[TBL] [Abstract][Full Text] [Related]
17. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I
Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511
[TBL] [Abstract][Full Text] [Related]
18. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
19. [Thalidomide used by patients with erythema nodosum leprosum].
Valente Mdo S; Vieira JL
Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
Upputuri B; Pallapati MS; Tarwater P; Srikantam A
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]